Książki na temat „Small Cell Lung Cancer”

Seeber, Siegfried, red. Small Cell Lung Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-82372-5.

Ramaswamy, Govindan, red. Locally advanced non-small-cell lung cancer. Manhasset, NY: CMP United Business Media, 2004.

Carr, David T. Selected abstracts on small cell lung cancer. Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1986.

1935-, Skarin Arthur T., i Alexander Eben, red. Multimodality treatment of lung cancer. New York: M. Dekker, 2000.

Govindan, Ramaswamy. Recent advances in locally advanced non-small-cell lung cancer. Manhasset, N.Y: CMPMedica, 2006.

IASLC Workshop on Small Cell Lung Cancer (3rd 1989 Helsingør, Denmark). Management of small cell lung cancer: Third IASLC Workshop on Small Cell Lung Cancer, Elsinore, Denmark, 18-22 June, 1989. Redaktorzy Hansen Heine Høi, Kristjansen Paul E. G i International Association for the Study of Lung Cancer. Amsterdam: Elsevier, 1989.

M, Marangolo, i Fiorentini G, red. Small cell lung cancer: Proceedings of the International Conference on Small Cell Lung Cancer, 27-28 March 1987, Ravenna, Italy. Oxford: Pergamon Press, 1988.

International Workshop on Small Cell Lung Cancer Antigens (2nd 1990 Royal Society of Medicine). Small cell lung cancer antigens: Proceedings of the Second International Workshop on Small Cell Lung Cancer Antigens held at the Royal Society of Medicine, 25-27 April 1990. [Basingstoke, Hampshire: published for Cancer Research Campaign by Macmillan, 1991.

Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

Ettinger, David S. The role of chemotherapy in non-small cell lung cancer. Syracuse, NY: Bristol Laboratories Oncology Products, Bristol-Myers Oncology Division, 1986.

Bunn, Paul A. VePesid (etoposide injection), its role in small cell lung cancer. Syracuse, N.Y: Bristol-Myers, Oncology Division, 1985.

author, Bujamma D., i M., Naresh Babu (Muppalaneni), author, red. Bioinformatics of non small cell lung cancer and the ras proto-oncogene. Heidelberg: Springer-Verlag, 2015.

1948-, Johnson David H., i Klastersky J, red. Taxanes in lung cancer therapy. New York: Marcel Dekker, 1998.

McCracken, Joseph D. Concurrent chemotherapy and radiation therapy for limited small cell lung cancer. Syracuse, N.Y: Bristol-Myers, Oncology Division, 1986.

Maldonado, Jonathon G. Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

Banerjee, Srabani. Treatment of inoperable advanced non-small-cell lung cancer: Regimens with or without taxane. Ottawa: Canadian Coordinating Office for Health Technology Assessment, 2002.

Young, Sean Steven. Lactic acid transport in small cell lung cancer cell lines NCI-H69 and NCI-H69AR. Sudbury, Ont: Laurentian University Press, 1995.

Kashyap, Amita, D. Bujamma i Naresh Babu M. Bioinformatics of Non Small Cell Lung Cancer and the Ras Proto-Oncogene. Singapore: Springer Singapore, 2015. http://dx.doi.org/10.1007/978-981-4585-08-8.

Maldonado, Jonathon G., i Mikayla K. Cervantes. Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

Bernhard, Jürg. "Lebensqualität" in onkologischen Therapiestudien: Konzepte, Methodik und Anwendung am Beispiel des Kleinzelligen Bronchuskarzinoms. Bern: P. Lang, 1992.

Dubois, Natalie C. Inhibition of small cell lung cancer cell line (H-69) with the calcium channel blocker, Verapamil. Sudbury, Ont: Laurentian University, 1995.

Ross, Jama. Energy metabolism in small cell lung cancer lines H-69 and H-69AR. Sudbury, Ont: Laurentian University, 1995.

Birnkrant, David Jonathan. Small cell cancer of the lung: An initial evaluation of the Yale treatment protocol. [New Haven: s.n.], 1985.

Ozog, Mark. The energy metabolism of a small cell lung cancer cell line, H69, and its drug resistant derivative, H69AR. Sudbury, Ont: Laurentian University, Department of Biology, 1995.

Mazzuchin, Chris. Inhibition of lactic acid transport in small cell lung cancer H69 by alpha-cyano-3-hydroxycinnamate. Sudbury, Ont: Laurentian University, 1995.

Hann, Brad. The Inhibitory effects of alpha-cyano-4-hydroxycinnamic acid on the lactate transporter of H69 small cell lung cancer cells. Sudbury, Ont: Laurentian University, 1995.

Tammemagi, Martin Carl. Tobacco smoking, p53 tumour suppressor gene alterations, and clinicopathologic features and prognosis in non-small cell lung cancer. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1998.

Smith, Ronald Dee. Veterinary clinical epidemiology. Wyd. 3. Boca Raton: CRC/Taylor & Francis, 2006.

Smith, Ronald Dee. Veterinary clinical epidemiology: A problem-oriented approach. Wyd. 2. Boca Raton: CRC Press, 1995.

Wake, Beverley. Hyperfractionated-accelerated radiotherapy regimens for the treatment of non-small cell lung cancer: A systematic review of clinical and cost-effectiveness. Birmingham: University of Birmingham, Department of Public Health and Epidemiology, 2002.

Rogers, M. J. A phenomenological investigation of the patient's experience in the first month following palliative radiotherapy for non-small cell lung cancer. Oxford: Oxford Brookes University, 2000.

Smith, Ronald Dee. Veterinary clinical epidemiology: A problem-oriented approach. Boston: Butterworth-Heinemann, 1991.

Muldoon, Lori. Glucose, lactate, and lactate dehydrogenase activity of the small cell lung cancer line H-209 and the drug resistant variant H-209/V6. Sudbury, Ont: Laurentian University, 1992.

Plönes, Till. Serum level of CC-chemokine ligand 18 is increased in patients with non-small-cell lung cancer and correlates with survival time in adenocarcinomas. Freiburg: Universität, 2012.

Hastie, G. Michael. Ribonucleic acid isolation from small cell lung carcinomas. Sudbury, Ont: Laurentian University, 1992.

Moreira, Andre Luis, i Anjali Saqi. Diagnosing non-small cell carcinoma in small biopsy and cytology. New York: Springer, 2015.

1949-, Bernal Samuel D., Hesketh Paul J. 1952- i International Conference on Lung Cancer (1990), red. Lung cancer differentiation: Implications for diagnosis and treatment. New York: Marcel Dekker, Inc., 1992.

Yaqoob, Nausheen. Desmoplastic small round cell tumor. New York: Nova Biomedical Books, 2012.

Portelance, Eric. The effect of carboxypeptidase N on small cell lung carcinoma cells. Sudbury, Ont: Laurentian University, 1991.

Seeber, Siegfried. Small Cell Lung Cancer. Springer, 2011.

S, Seeber, red. Small cell lung cancer. Berlin: Springer-Verlag, 1985.

Seeber, Siegfried. Small Cell Lung Cancer. Springer, 2012.

Seeber, Siegfried, i Alexander Petroianu. Small Cell Lung Cancer. Brand: Springer, 2012.

Azzoli, Christopher G. Non-Small Cell Lung Cancer. Jones & Bartlett Learning, LLC, 2009.

Non-small cell lung cancer. Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1988.

T, Carr David, i International Cancer Research Data Bank., red. Non-small cell lung cancer. Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1988.

Hansen, Heine H. Management of Small Cell Lung Cancer. Elsevier Science Ltd, 1990.

Jerome, Seidenfeld, Blue Cross and Blue Shield Association. Technology Evaluation Center. i United States. Agency for Healthcare Research and Quality., red. Management of small cell lung cancer. Rockville, MD: Agency for Healthcare Research and Quality, Public Health Service, U.S. Dept. of Health and Human Services, 2006.

Giaccone, Giuseppe. Systemic Treatment of Non-Small Cell Lung Cancer. Oxford University Press, 2012.

Non-Small Cell Lung Cancer: New Research. Nova Science Pub Inc, 2013.